Form 8-K - Current report:
SEC Accession No. 0001104659-25-016127
Filing Date
2025-02-21
Accepted
2025-02-21 16:04:40
Documents
16
Period of Report
2025-02-21
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257266d2_8k.htm   iXBRL 8-K 26122
2 EXHIBIT 5.1 tm257266d2_ex5-1.htm EX-5.1 14017
6 GRAPHIC tm25766d2_ex5-1img001.jpg GRAPHIC 3565
7 GRAPHIC tm25766d2_ex5-1img002.jpg GRAPHIC 5063
  Complete submission text file 0001104659-25-016127.txt   228639

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fold-20250221.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20250221_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20250221_pre.xml EX-101.PRE 22379
18 EXTRACTED XBRL INSTANCE DOCUMENT tm257266d2_8k_htm.xml XML 3552
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 25651659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)